Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Capital/Financing Update 2025

Apr 1, 2025

61176_rns_2025-04-01_bd59f370-d471-4a3e-81d2-6036614208cc.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [132 x 53] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T: 91 80 2808 2808 F: 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

BIO/SECL/SP/2025-26/01

April 01, 2025

To, To, The Secretary The Secretary BSE Limited National Stock Exchange of India Limited Department of Corporate Services Corporate Communication Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Mumbai – 400 050 Scrip Code – 532523 Scrip Symbol - Biocon

Dear Sir/ Madam,

Subject: Intimation for the Board Meeting pursuant to Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, April 04, 2025, inter alia, to consider and approve the raising of funds through issuance of Commercial Papers (CPs) or through any other mode on private placement basis.

The above-mentioned information will also be available on the website of the Company at www.biocon.com.

Kindly take the above information on record and acknowledge.

Thanking You,

For Biocon Limited

MAYA Digitally signed by MAYANK NK VERMA Date: 2025.04.01 VERMA 20:47:52 +05'30' _______________

Mayank Verma

==> picture [73 x 76] intentionally omitted <==

Company Secretary and Compliance Officer Membership No.: ACS 18776